Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., . . . Varmus, H. (2005). Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated with a Second Mutation in the EGFR Kinase Domain. Public Library of Science.

Pao, William, Vincent A. Miller, Katerina A. Politi, Gregory J. Riely, Romel Somwar, Maureen F. Zakowski, Mark G. Kris, and Harold Varmus. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated With a Second Mutation in the EGFR Kinase Domain. Public Library of Science, 2005.

Pao, William, et al. Acquired Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib Is Associated With a Second Mutation in the EGFR Kinase Domain. Public Library of Science, 2005.